HomeNewslettersHuman Immunology NewsTumor-Infiltrating Lymphocytes Refine Outcomes in Triple-Negative Breast Cancer Treated with Anthracycline-Free Neoadjuvant...
Scientists highlighted the role of stromal tumor-infiltrating lymphocytes in patient selection/stratification for neo/adjuvant escalation and de-escalation strategies.